METTL22 Activators

Forskolin stands out as it raises intracellular cAMP levels, resulting in the activation of PKA, a kinase that can phosphorylate substrate proteins to influence METTL22's activity. Ionomycin, by increasing cytoplasmic calcium levels, precipitates the activation of calcium-dependent kinases, which may also phosphorylate proteins within METTL22's network, thereby affecting its function. PMA, a direct activator of PKC, leads to the phosphorylation of a variety of proteins, which can indirectly affect the regulatory pathways of METTL22.

Trichostatin A and Suberoylanilide Hydroxamic Acid inhibit histone deacetylases, causing changes in chromatin structure that can result in increased expression of proteins that influence METTL22 regulation. 5-Azacytidine and Epigallocatechin gallate, inhibitors of DNA methyltransferases, similarly induce changes in gene expression, potentially impacting METTL22 activity. The influence on METTL22 extends to Lithium chloride's inhibition of GSK-3 and MG132's blockade of the proteasome, both of which can lead to altered protein interaction networks and stabilization of proteins that regulate METTL22. Sodium butyrate, another HDAC inhibitor, promotes gene expression changes by influencing histone acetylation, potentially enhancing METTL22 activity. Spermidine, through autophagy induction, and Resveratrol, by activating sirtuins, can affect protein acetylation and gene expression profiles, with downstream effects on METTL22 regulation.